Sustainable HIV treatment in Africa through viral-load-informed differentiated care
Open Access
- 2 December 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 528 (7580), S68-S76
- https://doi.org/10.1038/nature16046
Abstract
There are inefficiencies in current approaches to monitoring patients on antiretroviral therapy in sub-Saharan Africa. Patients typically attend clinics every 1 to 3 months for clinical assessment. The clinic costs are comparable with the costs of the drugs themselves and CD4 counts are measured every 6 months, but patients are rarely switched to second-line therapies. To ensure sustainability of treatment programmes, a transition to more cost-effective delivery of antiretroviral therapy is needed. In contrast to the CD4 count, measurement of the level of HIV RNA in plasma (the viral load) provides a direct measure of the current treatment effect. Viral-load-informed differentiated care is a means of tailoring care so that those with suppressed viral load visit the clinic less frequently and attention is focussed on those with unsuppressed viral load to promote adherence and timely switching to a second-line regimen. The most feasible approach to measuring viral load in many countries is to collect dried blood spot samples for testing in regional laboratories; however, there have been concerns over the sensitivity and specificity of this approach to define treatment failure and the delay in returning results to the clinic. We use modelling to synthesize evidence and evaluate the cost-effectiveness of viral-load-informed differentiated care, accounting for limitations of dried blood sample testing. We find that viral-load-informed differentiated care using dried blood sample testing is cost-effective and is a recommended strategy for patient monitoring, although further empirical evidence as the approach is rolled out would be of value. We also explore the potential benefits of point-of-care viral load tests that may become available in the future. This article has not been written or reviewed by Nature editors. Nature accepts no responsibility for the accuracy of the information provided.Keywords
This publication has 52 references indexed in Scilit:
- Switching HIV Treatment in Adults Based on CD4 Count Versus Viral Load Monitoring: A Randomized, Non-Inferiority Trial in ThailandPLoS Medicine, 2013
- Toward an Understanding of Disengagement from HIV Treatment and Care in Sub-Saharan Africa: A Qualitative StudyPLoS Medicine, 2013
- Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trialThe Lancet Infectious Diseases, 2011
- The cost of providing comprehensive HIV treatment in PEPFAR-supported programsAIDS, 2011
- Cost Effectiveness of a Pharmacy-Only Refill Program in a Large Urban HIV/AIDS Clinic in UgandaPLOS ONE, 2011
- Alternative antiretroviral monitoring strategies for HIV‐infected patients in east Africa: opportunities to save more lives?Journal of the International AIDS Society, 2011
- Laboratory Monitoring to Guide Switching Antiretroviral Therapy in Resource-Limited Settings: Clinical Benefits and Cost-EffectivenessJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trialThe Lancet, 2009
- Correlation between Human Immunodeficiency Virus Type 1 (HIV-1) RNA Measurements Obtained with Dried Blood Spots and Those Obtained with Plasma by Use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV Load TestsJournal of Clinical Microbiology, 2009
- Cost-effectiveness of HIV Monitoring Strategies in Resource-Limited SettingsJAMA Internal Medicine, 2008